Detect the presence of Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida lusitaniae, and Candida krusei DNA in vaginal samples as an aid to the diagnosis of vulvovaginal candidiasis in symptomatic women
Candida parapsilosis cannot be differentiated from Candida metapsilosis or Candida orthopsilosis using this assay.
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary.